In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Veterinary Pharmacology and Therapeutics

• Publication date

  2013-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2885.2012.01398.xPMID 22486410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

  2011cited by this paper
• Interspecies variations in small intestinal and hepatic drug hydroxylation and glucuronidation.

  2009cited by this paper
• Effect of control of systolic blood pressure on survival in cats with systemic hypertension.

  2007cited by this paper
• cDNA cloning and characterization of feline CYP1A1 and CYP1A2.

  2006cited by this paper
• A Review on Telmisartan: A Novel, Long-Acting Angiotensin II-Receptor Antagonist

  2006cited by this paper
• Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria.

  2006cited by this paper
• Tolerability and efficacy of benazepril in cats with chronic kidney disease.

  2006cited by this paper
• Angiotensin-converting enzyme inhibitors in the therapy of renal diseases.

  2004cited by this paper
• The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases.

  2003cited by this paper
• Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency.

  2001cited by this paper
• Angiotensin II receptor antagonists.

  2000cited by this paper
• In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.

  2000cited by this paper
• Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms.

  2000cited by this paper
• Disposition and chemical stability of telmisartan 1-O-acylglucuronide.

  1999cited by this paper
• Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models.

  1997cited by this paper
• Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes.

  1997cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

  1996cited by this paper
• Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family.

  1993cited by this paper
• A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver.

  1986cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• An improved assay technique for uridine diphosphate glucuronosyltransferase activity towards 5-hydroxytryptamine and some properties of the enzyme.

  1978cited by this paper
• Drug metabolism in ”exotic” animals

  1978cited by this paper
• Lorazepam: glucuronide formation in the cat.

  1975cited by this paper
• The enzyme-catalyzed formation of bilirubin diglucuronide by a solubilized preparation from cat liver microsomes

  1974cited by this paper
• The fate of sulphadimethoxine in primates compared with other species.

  1970cited by this paper

• Clinical therapeutics in feline medicine: updates for old and new drugs

  2025cites this paper
• In Silico Approach For Detection Of The Effect Of UGT1A1 Polymorphisms On Telmisartan Response

  2022cites this paper
• Single‐dose pharmacokinetics of telmisartan oral solution and effect of feeding in dogs

  2022cites this paper
• Hypertension in the Dog and Cat

  2020cites this paper
• Pharmacology of Antihypertensive Drugs

  2020cites this paper
• Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study

  2018cites this paper
• Physiology, Pathophysiology, and Anesthetic Management of Patients with Hepatic Disease

  2017cites this paper
• Toxicological potential of acyl glucuronides and its assessment.

  2017cites this paper
• ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease Practical relevance

  2016cites this paper
• ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease

  2016cites this paper
• Cats, Cancer and Comparative Oncology

  2015cites this paper
• To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics

  2015cites this paper
• Feline hepatic biotransformation of diazepam: Differences between cats and dogs.

  2015cites this paper
• Cardiovascular endocrinology in naturally occurring canine and feline models

  2014cites this paper
• Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.

  2014cites this paper
• Comparing the glucuronidation capacity of the feline liver with substrate-specific glucuronidation in dogs.

  2014cites this paper
• Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.

  2013cites this paper
• Feline CKD

  2013cites this paper